Analytical Data
-
Gene name
Stfa1
- Application
-
Alternative Names
Stfa1; Stf-1; Stf1Stefin-1
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P35175
-
Expression Region
1-97aa
-
Molecular Weight
16.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Stfa1, derived from the *Staphylococcus aureus* species, is a noteworthy protein that has garnered interest in the field of microbiology and biotechnology due to its potential applications in various domains. Research into Stfa1 focuses primarily on its role as a virulence factor, contributing to the pathogenicity of *S. aureus* infections, which are a significant concern in both clinical and community settings. The protein operates through mechanisms that enable *S. aureus* to evade host immune responses, thus facilitating persistent infections. Given the rising prevalence of antibiotic-resistant strains of *S. aureus*, understanding the structure and function of Stfa1 can provide insights into novel therapeutic approaches. Furthermore, the recombinant production of Stfa1 facilitates in-depth studies on its biochemical properties and interactions, paving the way for the development of targeted interventions, such as vaccines or enzyme inhibitors. Thus, research on Stfa1 not only enhances our understanding of staphylococcal biology but also holds promise for innovative strategies to combat infections caused by this formidable bacterium.
